Europe — EMA

Paclitaxel Fresenius Kabi

Paclitaxel, the active ingredient in Paclitaxel Fresenius Kabi, is a chemotherapy agent presented as a sterile injectable solution for intravenous use.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Fresenius Kabi, is a chemotherapy agent presented as a sterile injectable solution for intravenous use. It treats various solid tumours and is used in adult oncology patients. GNH USA supplies Paclitaxel Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and oncology centres worldwide.

GNH USA supplies Paclitaxel Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and oncology centres worldwide.

What is Paclitaxel used for?

Paclitaxel is a taxane class chemotherapeutic that interferes with micro‑tubule dynamics in cancer cells.

- Breast cancer: improves survival when used in adjuvant or metastatic settings. - Non‑small cell lung cancer: used in combination regimens to extend progression‑free survival. - Ovarian cancer: administered after surgery to reduce recurrence risk. - Gastric cancer: part of combination therapy for advanced disease. - Kaposi's sarcoma: provides disease control in HIV‑related cases. - Pancreatic cancer: used in combination protocols for metastatic disease.

What are the side effects of Paclitaxel?

Paclitaxel may exhibit the following adverse reactions.

Common Side Effects: - Neutropenia : low the ... - S ... - ... - ... - ... - ...

Serious or Rare ... ":[ - ");

Precautions: - ");

Interactions: - """

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →